{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T01:23:48Z","timestamp":1786757028372,"version":"build-2736575974"},"reference-count":249,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Clinical studies on effects of marine-derived omega-3 (n-3) polyunsaturated fatty acids (PUFAs), mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and the plant-derived omega-6 (n-6) PUFA linoleic acid (LA) on lipoprotein-lipid components and glucose-insulin homeostasis have shown conflicting results, which may partly be explained by differential responses in females and males. However, we have lacked data on sexual dimorphism in the response of cardiometabolic risk markers following increased consumption of n-3 or n-6 PUFAs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore sex-specific responses after n-3 (EPA\u2009+\u2009DHA) or n-6 (LA) PUFA supplementation on circulating lipoprotein subfractions, standard lipids, apolipoproteins, fatty acids in red blood cell membranes, and markers of glycemic control\/insulin sensitivity among people with abdominal obesity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a randomized double-blind crossover study with two 7-week intervention periods separated by a 9-week washout phase. Females (<jats:italic>n<\/jats:italic>\u2009=\u200916) were supplemented with 3\u2009g\/d of EPA\u2009+\u2009DHA (fish oil) or 15\u2009g\/d of LA (safflower oil), while males (<jats:italic>n<\/jats:italic>\u2009=\u200923) received a dose of 4\u2009g\/d of EPA\u2009+\u2009DHA or 20\u2009g\/d of LA. In fasting blood samples, we measured lipoprotein particle subclasses, standard lipids, apolipoproteins, fatty acid profiles, and markers of glycemic control\/insulin sensitivity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The between-sex difference in relative change scores was significant after n-3 for total high-density lipoproteins (females\/males: \u221211%*\/\u22123.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.036; *: significant within-sex change), high-density lipoprotein particle size (+2.1%*\/\u22120.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.045), and arachidonic acid (\u22128.3%*\/\u221212%*, <jats:italic>p<\/jats:italic>\u2009=\u20090.012), and after n-6 for total (+37%*\/+2.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.041) and small very-low-density lipoproteins (+97%*\/+14%, <jats:italic>p<\/jats:italic>\u2009=\u20090.021), and lipoprotein (a) (\u221216%*\/+0.1%, <jats:italic>p<\/jats:italic>\u2009=\u20090.028). Circulating markers of glucose-insulin homeostasis differed significantly after n-3 for glucose (females\/males: \u22122.1%\/+3.9%*, <jats:italic>p<\/jats:italic>\u2009=\u20090.029), insulin (\u221231%*\/+16%, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001), insulin C-peptide (\u221212%*\/+13%*, <jats:italic>p<\/jats:italic>\u2009=\u20090.001), homeostasis model assessment of insulin resistance index 2 (\u221212%*\/+14%*, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) and insulin sensitivity index 2 (+14%*\/\u221212%*, <jats:italic>p<\/jats:italic>\u2009=\u20090.001), and quantitative insulin sensitivity check index (+4.9%*\/\u22123.4%*, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We found sex-specific responses after high-dose n-3 (but not n-6) supplementation in circulating markers of glycemic control\/insulin sensitivity, which improved in females but worsened in males. This may partly be related to the sex differences we observed in several components of the lipoprotein-lipid profile following the n-3 intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>https:\/\/clinicaltrials.gov\/<\/jats:ext-link>, identifier [NCT02647333].<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2023.1020678","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T05:17:37Z","timestamp":1687151857000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Sex-specific responses in glucose-insulin homeostasis and lipoprotein-lipid components after high-dose supplementation with marine n-3 PUFAs in abdominal obesity: a randomized double-blind crossover study"],"prefix":"10.3389","volume":"10","author":[{"given":"Johnny","family":"Laupsa-Borge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Grytten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavol","family":"Bohov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil","family":"Bj\u00f8rndal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Skorve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Erik","family":"Nordrehaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf K.","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen","family":"Rostrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Mellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon N.","family":"Dankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottar K.","family":"Nyg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"d5170","DOI":"10.1136\/bmj.d5170","article-title":"Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data","volume":"343","author":"Vaidya","year":"2011","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/s0140-6736(20)30543-2","article-title":"Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (pure): a prospective cohort study","volume":"396","author":"Walli-Attaei","year":"2020","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics \u2013 2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s11883-005-0065-6","article-title":"Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease","volume":"7","author":"Knopp","year":"2005","journal-title":"Curr Atheroscler Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1914S","DOI":"10.3945\/ajcn.110.000893","article-title":"Sex-specific differences in essential fatty acid metabolism","volume":"94","author":"Decsi","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00021.2015","article-title":"Mechanistic pathways of sex differences in cardiovascular disease","volume":"97","author":"Regitz-Zagrosek","year":"2017","journal-title":"Physiol Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.008","article-title":"Sex differences in lipid and lipoprotein metabolism","volume":"15","author":"Palmisano","year":"2018","journal-title":"Mol Metab"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","article-title":"Sexual dimorphism in Cardiometabolic health: the role of adipose tissue","volume":"17","author":"Goossens","year":"2021","journal-title":"Muscle and Liver Nat Rev Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1017\/S0029665108005983","article-title":"Gender differences in the N-3 fatty acid content of tissues","volume":"67","author":"Childs","year":"2008","journal-title":"Proc Nutr Soc"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000345599","article-title":"Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications","volume":"62","author":"Lohner","year":"2013","journal-title":"Ann Nutr Metab"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1017\/S000711451800106X","article-title":"Association of oily fish intake, sex, age, BMI and APOE genotype with plasma long-chain N-3 fatty acid composition","volume":"120","author":"Fisk","year":"2018","journal-title":"Br J Nutr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/nu12020310","article-title":"Genome-wide association study for serum omega-3 and omega-6 polyunsaturated fatty acids: exploratory analysis of the sex-specific effects and dietary modulation in Mediterranean subjects with metabolic syndrome","volume":"12","author":"Coltell","year":"2020","journal-title":"Nutrients"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/ajcn\/74.1.64","article-title":"Association of sex, adiposity, and diet with HDL subclasses in middle-aged Chinese","volume":"74","author":"Lyu","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/nu6051850","article-title":"Relationship between erythrocyte omega-3 content and obesity is gender dependent","volume":"6","author":"Howe","year":"2014","journal-title":"Nutrients"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jacl.2016.02.002","article-title":"Sex differences in the associations of visceral adiposity, homeostatic model assessment of insulin resistance, and body mass index with lipoprotein subclass analysis in obese adolescents","volume":"10","author":"Hatch-Stein","year":"2016","journal-title":"J Clin Lipidol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2169\/internalmedicine.55.5624","article-title":"Sex differences in the association between the eicosapentaenoic acid\/arachidonic acid ratio and the visceral fat area among patients with type 2 diabetes","volume":"55","author":"Nakanishi","year":"2016","journal-title":"Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/er.2018-00184","article-title":"The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk","volume":"40","author":"Sandesara","year":"2018","journal-title":"Endocr Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11883-020-00846-8","article-title":"Triglycerides and ASCVD risk reduction: recent insights and future directions","volume":"22","author":"Hussain","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jacl.2020.04.009","article-title":"The association between triglycerides and incident cardiovascular disease: what is \u201coptimal\u201d?","volume":"14","author":"Aberra","year":"2020","journal-title":"J Clin Lipidol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.atv.18.7.1046","article-title":"Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease","volume":"18","author":"Freedman","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.cir.0000033222.75187.b9","article-title":"Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women","volume":"106","author":"Blake","year":"2002","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2337\/diabetes.51.6.1949","article-title":"Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes","volume":"51","author":"Colhoun","year":"2002","journal-title":"Diabetes"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11883-003-0036-8","article-title":"The concept of apolipoprotein-defined lipoprotein families and its clinical significance","volume":"5","author":"Alaupovic","year":"2003","journal-title":"Curr Atheroscler Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jacl.2007.10.001","article-title":"LDL particle number and risk of future cardiovascular disease in the framingham offspring study: implications for LDL management","volume":"1","author":"Cromwell","year":"2007","journal-title":"J Clin Lipidol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/circulationaha.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women","volume":"119","author":"Mora","year":"2009","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1161\/atvbaha.109.190405","article-title":"Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk","volume":"29","author":"Musunuru","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MOL.0b013e32833b7756","article-title":"Lipoprotein subfractions and cardiovascular disease risk","volume":"21","author":"Krauss","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrcardio.2010.223","article-title":"Lipid parameters for measuring risk of cardiovascular disease","volume":"8","author":"Arsenault","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jacl.2015.05.002","article-title":"The risk of cardiovascular events with increased apolipoprotein CIII: a systematic review and meta-analysis","volume":"9","author":"Wyler von Ballmoos","year":"2015","journal-title":"J Clin Lipidol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/s0022-2275(20)37553-2","article-title":"Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes","volume":"37","author":"Li","year":"1996","journal-title":"J Lipid Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/s0021-9150(01)00579-2","article-title":"HDL particle size: a marker of the gender difference in the metabolic risk profile","volume":"160","author":"Pascot","year":"2002","journal-title":"Atherosclerosis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1373\/clinchem.2004.032763","article-title":"Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the framingham study","volume":"50","author":"Freedman","year":"2004","journal-title":"Clin Chem"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.metabol.2008.01.019","article-title":"The Association of endogenous sex hormones with lipoprotein subfraction profile in the multi-ethnic study of atherosclerosis","volume":"57","author":"Vaidya","year":"2008","journal-title":"Metabolism"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ahj.2016.09.012","article-title":"Sex differences in lipid profiles and treatment utilization among young adults with acute myocardial infarction: results from the VIRGO study","volume":"183","author":"Lu","year":"2017","journal-title":"Am Heart J"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1476-511X-10-162","article-title":"Observational study of lipid profile and LDL particle size in patients with metabolic syndrome","volume":"10","author":"Sancho-Rodr\u00edguez","year":"2011","journal-title":"Lipids Health Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1017\/S0007114519001429","article-title":"Sex differences in postprandial responses to different dairy products on lipoprotein subclasses: a randomised controlled cross-over trial","volume":"122","author":"Hansson","year":"2019","journal-title":"Br J Nutr"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/01.atv.7.5.483","article-title":"Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: results from the framingham offspring study","volume":"7","author":"McNamara","year":"1987","journal-title":"Arteriosclerosis"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1161\/01.atv.12.3.332","article-title":"Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women","volume":"12","author":"Williams","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1161\/01.atv.15.11.1839","article-title":"Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women","volume":"15","author":"Tan","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1161\/01.atv.17.12.3513","article-title":"Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects","volume":"17","author":"Tilly-Kiesi","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/ajcn\/88.3.618","article-title":"Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN study","volume":"88","author":"Caslake","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1161\/ATVBAHA.108.163931","article-title":"Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women","volume":"28","author":"Matthan","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.maturitas.2015.02.262","article-title":"Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions","volume":"81","author":"Anagnostis","year":"2015","journal-title":"Maturitas"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s11745-017-4307-5","article-title":"Sex differences in blood HDL-C, the total cholesterol\/HDL-C ratio, and palmitoleic acid are not associated with variants in common candidate genes","volume":"52","author":"Klingel","year":"2017","journal-title":"Lipids"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1567-5688(13)70005-9","article-title":"Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: a meta-analysis of randomized, double blind, placebo controlled trials","volume":"14","author":"Casula","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/jhn.12493","article-title":"Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials","volume":"31","author":"AbuMweis","year":"2018","journal-title":"J Hum Nutr Diet"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e013543","DOI":"10.1161\/JAHA.119.013543","article-title":"Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants","volume":"8","author":"Hu","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/ijms21041362","article-title":"Marine omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020","volume":"21","author":"Innes","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41467-021-22370-2","article-title":"Blood N-3 fatty acid levels and Total and cause-specific mortality from 17 prospective studies","volume":"12","author":"Harris","year":"2021","journal-title":"Nat Commun"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2022.06.1018","article-title":"Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: implications for primary prevention","volume":"353","author":"Alfaddagh","year":"2022","journal-title":"Atherosclerosis"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/circulationaha.114.010236","article-title":"Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies","volume":"130","author":"Farvid","year":"2014","journal-title":"Circulation"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000000510","article-title":"Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association","volume":"136","author":"Sacks","year":"2017","journal-title":"Circulation"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1161\/CIRCULATIONAHA.118.038908","article-title":"Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality: an individual-level pooled analysis of 30 cohort studies","volume":"139","author":"Marklund","year":"2019","journal-title":"Circulation"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2019.11.018","article-title":"Dietary linoleic acid and human health: focus on cardiovascular and cardiometabolic effects","volume":"292","author":"Marangoni","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55\u2008000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.3390\/nu12082329","article-title":"The effects of linoleic acid consumption on lipid risk markers for cardiovascular disease in healthy individuals: a review of human intervention trials","volume":"12","author":"Froyen","year":"2020","journal-title":"Nutrients"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1645S","DOI":"10.1093\/ajcn\/65.5.1645S","article-title":"N-3 fatty acids and serum lipoproteins: human studies","volume":"65","author":"Harris","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/ajcn\/77.2.300","article-title":"Randomized controlled trial of the effect of N\u20133 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity","volume":"77","author":"Chan","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3945\/ajcn.110.003871","article-title":"Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia","volume":"93","author":"Skulas-Ray","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11883-011-0210-3","article-title":"Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis","volume":"13","author":"Wei","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12944-015-0049-7","article-title":"A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals","volume":"14","author":"Leslie","year":"2015","journal-title":"Lipids Health Dis"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1628S","DOI":"10.1093\/ajcn\/65.5.1628S","article-title":"Individual fatty acid effects on plasma lipids and lipoproteins: human studies","volume":"65","author":"Kris-Etherton","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","article-title":"Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials","volume":"77","author":"Mensink","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/advances\/nmy038","article-title":"\u03a9-6 polyunsaturated fatty acids and cardiometabolic health: current evidence, controversies, and research gaps","volume":"9","author":"Maki","year":"2018","journal-title":"Adv Nutr"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the strength randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1001\/jama.2020.22387","article-title":"Effects of omega-3 fatty acids on major adverse cardiovascular events: what matters most: the drug, the dose, or the placebo?","volume":"324","author":"Sharma","year":"2020","journal-title":"JAMA"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/jn\/nxac084","article-title":"A randomized trial of omega-3 fatty acid supplementation and circulating lipoprotein subclasses in healthy older adults","volume":"152","author":"Moosavi","year":"2022","journal-title":"J Nutr"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1017\/S0007114510004010","article-title":"N-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials","volume":"104","author":"Ramsden","year":"2010","journal-title":"Br J Nutr"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12937-017-0254-5","article-title":"The effect of replacing saturated fat with mostly N-6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials","volume":"16","author":"Hamley","year":"2017","journal-title":"Nutr J"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"CD011094","DOI":"10.1002\/14651858.CD011094.pub4","article-title":"Omega-6 fats for the primary and secondary prevention of cardiovascular disease","volume":"11","author":"Hooper","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"CD003177","DOI":"10.1002\/14651858.CD003177.pub5","article-title":"Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease","volume":"3","author":"Abdelhamid","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev-nutr-071816-064614","article-title":"Dietary fat and risk of cardiovascular disease: recent controversies and advances","volume":"37","author":"Wang","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.115.015607","article-title":"Polyunsaturated fat intake estimated by circulating biomarkers and risk of cardiovascular disease and all-cause mortality in a population-based cohort of 60-year-old men and women","volume":"132","author":"Marklund","year":"2015","journal-title":"Circulation"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/ijms19020532","article-title":"The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiometabolic risk factors: a systematic review","volume":"19","author":"Innes","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1039\/c8fo00348c","article-title":"Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effects vs. clinical outcomes","volume":"9","author":"Thota","year":"2018","journal-title":"Food Funct"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1016\/j.clnu.2021.03.040","article-title":"Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with N-3 or N-6 PUFAs in abdominal obesity: a randomized double-blind crossover study","volume":"40","author":"Grytten","year":"2021","journal-title":"Clin Nutr"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1038\/srep06697","article-title":"Higher omega-3 index is associated with increased insulin sensitivity and more favourable metabolic profile in middle-aged overweight men","volume":"4","author":"Albert","year":"2014","journal-title":"Sci Rep"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.33549\/physiolres.932715","article-title":"The effect of N-3 fatty acids on glucose homeostasis and insulin sensitivity","volume":"63","author":"Flachs","year":"2014","journal-title":"Physiol Res"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3945\/ajcn.116.138172","article-title":"Do \u03a9-3 Pufas affect insulin resistance in a sex-specific manner? A systematic review and meta-analysis of randomized controlled trials","volume":"104","author":"Abbott","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/nu8060329","article-title":"Insulin-sensitizing effects of omega-3 fatty acids: lost in translation?","volume":"8","author":"Lalia","year":"2016","journal-title":"Nutrients"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"102154","DOI":"10.1016\/j.plefa.2020.102154","article-title":"Dha-enriched Fish oil reduces insulin resistance in overweight and obese adults","volume":"159","author":"Abbott","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e000871","DOI":"10.1136\/bmjdrc-2019-000871","article-title":"Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism","volume":"8","author":"Green","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2217\/clp.09.72","article-title":"Trafficking and partitioning of fatty acids: the transition from fasted to fed state","volume":"5","author":"Hodson","year":"2010","journal-title":"Clin Lipidol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fendo.2014.00241","article-title":"Sex-specific differences in lipid and glucose metabolism","volume":"5","author":"Varlamov","year":"2015","journal-title":"Front Endocrinol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1083\/jcb.201903102","article-title":"Insulin activates intracellular transport of lipid droplets to release triglycerides from the liver","volume":"218","author":"Kumar","year":"2019","journal-title":"J Cell Biol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"e3399","DOI":"10.1002\/dmrr.3399","article-title":"Canola oil compared with sesame and sesame-canola oil on glycaemic control and liver function in patients with type 2 diabetes: a three-way randomized triple-blind cross-over trial","volume":"37","author":"Raeisi-Dehkordi","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12944-017-0515-5","article-title":"Effects of aerobic exercise on lipids and lipoproteins","volume":"16","author":"Wang","year":"2017","journal-title":"Lipids Health Dis"},{"key":"ref95","first-page":"42","article-title":"Inbody 720 as a new method of evaluating visceral obesity","volume":"58","author":"Ogawa","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2337\/dc09-1099","article-title":"Estimating visceral fat area by multifrequency bioelectrical impedance","volume":"33","author":"Nagai","year":"2010","journal-title":"Diabetes Care"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2147\/ijgm.S281418","article-title":"Standing 8-electrode bioelectrical impedance analysis as an alternative method to estimate visceral fat area and body fat mass in athletes","volume":"14","author":"Lee","year":"2021","journal-title":"Int J Gen Med"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1476-511X-11-82","article-title":"Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of N-3 fatty acids in rat","volume":"11","author":"Strand","year":"2012","journal-title":"Lipids Health Dis"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.plipres.2008.03.003","article-title":"Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake","volume":"47","author":"Hodson","year":"2008","journal-title":"Prog Lipid Res"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11745-012-3665-2","article-title":"Statistical methodological issues in handling of fatty acid data: percentage or concentration, imputation and indices","volume":"47","author":"Mocking","year":"2012","journal-title":"Lipids"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00394-016-1358-y","article-title":"Absolute versus relative measures of plasma fatty acids and health outcomes: example of phospholipid omega-3 and omega-6 fatty acids and all-cause mortality in women","volume":"57","author":"Miura","year":"2018","journal-title":"Eur J Nutr"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/s0002-9149(02)02632-2","article-title":"Measurement issues related to lipoprotein heterogeneity","volume":"90","author":"Otvos","year":"2002","journal-title":"Am J Cardiol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1210\/jcem.86.10.7902","article-title":"Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals","volume":"86","author":"Perseghin","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1089\/met.2014.0050","article-title":"Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance","volume":"12","author":"Shalaurova","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"e21403","DOI":"10.1371\/journal.pone.0021403","article-title":"Problems with using the normal distribution \u2013 and ways to improve quality and efficiency of data analysis","volume":"6","author":"Limpert","year":"2011","journal-title":"PLoS One"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s0895-4356(00)00314-0","article-title":"Adjusting for multiple testing\u2014when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"ref110","first-page":"134","article-title":"Longitudinal data analysis of continuous and discrete responses for pre-post designs","volume":"62","author":"Liang","year":"2000","journal-title":"Sankhy\u0101"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/sim.3639","article-title":"Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?","volume":"28","author":"Liu","year":"2009","journal-title":"Stat Med"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1541-0420.2009.01332.x","article-title":"On efficiency of constrained longitudinal data analysis versus longitudinal analysis of covariance","volume":"66","author":"Lu","year":"2010","journal-title":"Biometrics"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"e013096","DOI":"10.1136\/bmjopen-2016-013096","article-title":"To condition or not condition? Analysing \u2018change\u2019 in longitudinal randomised controlled trials","volume":"6","author":"Coffman","year":"2016","journal-title":"BMJ Open"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.conctc.2018.03.008","article-title":"Different ways to estimate treatment effects in randomised controlled trials","volume":"10","author":"Twisk","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/biostatistics\/kxp046","article-title":"The use of baseline covariates in crossover studies","volume":"11","author":"Kenward","year":"2010","journal-title":"Biostatistics"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1476-511X-11-42","article-title":"Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials","volume":"11","author":"Wang","year":"2012","journal-title":"Lipids Health Dis"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/10408360290795529","article-title":"Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis","volume":"39","author":"Hannuksela","year":"2002","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMoa020194","article-title":"Effects of the amount and intensity of exercise on plasma lipoproteins","volume":"347","author":"Kraus","year":"2002","journal-title":"N Engl J Med"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"d636","DOI":"10.1136\/bmj.d636","article-title":"Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies","volume":"342","author":"Brien","year":"2011","journal-title":"BMJ"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"e0148765","DOI":"10.1371\/journal.pone.0148765","article-title":"Causal role of alcohol consumption in an improved lipid profile: the atherosclerosis risk in communities (ARIC) study","volume":"11","author":"Vu","year":"2016","journal-title":"PLoS One"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1002\/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F","article-title":"Sympercents: symmetric percentage differences on the 100 loge scale simplify the presentation of log transformed data","volume":"19","author":"Cole","year":"2000","journal-title":"Stat Med"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","article-title":"Statistics notes: analysing controlled trials with baseline and follow up measurements","volume":"323","author":"Vickers","year":"2001","journal-title":"BMJ"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2288-5-35","article-title":"Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data","volume":"5","author":"Vickers","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1002\/sim.2682","article-title":"Change from baseline and analysis of covariance revisited","volume":"25","author":"Senn","year":"2006","journal-title":"Stat Med"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1191\/1740774505cn119oa","article-title":"Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials","volume":"2","author":"Beunckens","year":"2005","journal-title":"Clin Trials"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jclinepi.2011.11.012","article-title":"Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models","volume":"65","author":"Peters","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jclinepi.2013.03.017","article-title":"Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis","volume":"66","author":"Twisk","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"067013","DOI":"10.1289\/EHP334","article-title":"Statistical approaches for estimating sex-specific effects in endocrine disruptors research","volume":"125","author":"Buckley","year":"2017","journal-title":"Environ Health Perspect"},{"key":"ref129","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fpsyg.2012.00111","article-title":"A practical guide to calculating Cohen\u2019s F2, a measure of local effect size, from proc mixed","volume":"3","author":"Selya","year":"2012","journal-title":"Front Psychol"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40536-018-0061-2","article-title":"Effect size measures for multilevel models: definition, interpretation, and TIMSS example","volume":"6","author":"Lorah","year":"2018","journal-title":"Large Scale Assess Educ"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"l4378","DOI":"10.1136\/bmj.l4378","article-title":"Consort 2010 statement: extension to randomised crossover trials","volume":"366","author":"Dwan","year":"2019","journal-title":"BMJ"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"1997S","DOI":"10.1093\/ajcn\/87.6.1997S","article-title":"The omega-3 index as a risk factor for coronary heart disease","volume":"87","author":"Harris","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.plefa.2016.06.004","article-title":"Red blood cell Pufas reflect the phospholipid Pufa composition of major organs","volume":"112","author":"Fenton","year":"2016","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/s1262-3636(07)70133-7","article-title":"Role of the liver in the control of carbohydrate and lipid homeostasis","volume":"30","author":"Postic","year":"2004","journal-title":"Diabetes Metab"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1038\/emm.2015.122","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp Mol Med"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","article-title":"Fatty liver: a novel component of the metabolic syndrome","volume":"28","author":"Kotronen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/s1050-1738(01)00084-6","article-title":"Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance","volume":"11","author":"Adeli","year":"2001","journal-title":"Trends Cardiovasc Med"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2005.12.026","article-title":"Lipid and lipoprotein dysregulation in insulin resistant states","volume":"368","author":"Avramoglu","year":"2006","journal-title":"Clin Chim Acta"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/atvbaha.107.160192","article-title":"Overproduction of very low\u2013density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in obesity: mechanisms and potential targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fendo.2015.00182","article-title":"Sexual dimorphism in hepatic, adipose tissue, and peripheral tissue insulin sensitivity in obese humans","volume":"6","author":"Ter Horst","year":"2015","journal-title":"Front Endocrinol"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"103257","DOI":"10.1016\/j.isci.2021.103257","article-title":"Sex hormones drive changes in lipoprotein metabolism","volume":"24","author":"Robinson","year":"2021","journal-title":"iScience"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.3390\/ijms17122093","article-title":"Regulation of ketone body metabolism and the role of Ppar\u03b1","volume":"17","author":"Grabacka","year":"2016","journal-title":"Int J Mol Sci"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1467-789X.2008.00529.x","article-title":"Sex differences in obesity and the regulation of energy homeostasis","volume":"10","author":"Lovejoy","year":"2009","journal-title":"Obes Rev"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1139\/o11-067","article-title":"Sex differences in lipid metabolism and metabolic disease risk","volume":"90","author":"Sugiyama","year":"2012","journal-title":"Biochem Cell Biol"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4161\/adip.24075","article-title":"Sex differences in adipose tissue: it is not only a question of quantity and distribution","volume":"2","author":"Fuente-Mart\u00edn","year":"2013","journal-title":"Adipocytes"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/oby.21133","article-title":"Shaping fat distribution: new insights into the molecular determinants of depot- and sex-dependent adipose biology","volume":"23","author":"Fried","year":"2015","journal-title":"Obesity"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mce.2014.11.029","article-title":"The sexual dimorphism of obesity","volume":"402","author":"Palmer","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11306-015-0886-4","article-title":"Predictive associations between serum fatty acids and lipoproteins in healthy non-obese Norwegians: implications for cardiovascular health","volume":"12","author":"Lin","year":"2016","journal-title":"Metabolomics"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/mol.0000000000000536","article-title":"Sex differences in metabolism and cardiometabolic disorders","volume":"29","author":"Chella Krishnan","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ijo.2010.209","article-title":"Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome \u2013 lipgene: a European randomized dietary intervention study","volume":"35","author":"Tierney","year":"2011","journal-title":"Int J Obes"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1017\/S0007114516000258","article-title":"Sex-dependent association between erythrocyte N-3 PUFA and type 2 diabetes in older overweight people","volume":"115","author":"Abbott","year":"2016","journal-title":"Br J Nutr"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.clnu.2019.04.007","article-title":"Association between plasma phospholipid omega-3 polyunsaturated fatty acids and type 2 diabetes is sex dependent: the Hunter Community study","volume":"39","author":"Abbott","year":"2020","journal-title":"Clin Nutr"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despr\u00e9s","year":"1996","journal-title":"N Engl J Med"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"e52036","DOI":"10.1371\/journal.pone.0052036","article-title":"Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis","volume":"7","author":"Gast","year":"2012","journal-title":"PLoS One"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3945\/ajcn.113.065565","article-title":"Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies","volume":"98","author":"Xun","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.dsx.2019.02.023","article-title":"Insulin resistance is a cardiovascular risk factor in humans","volume":"13","author":"Adeva-Andany","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.prostaglandins.2013.05.003","article-title":"Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation","volume":"107","author":"Titos","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1080\/10408398.2015.1130016","article-title":"Polyunsaturated fatty acids and type 2 diabetes: impact on the glycemic control mechanism","volume":"57","author":"Coelho","year":"2017","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/oby.21033","article-title":"The role of androgens in metabolism, obesity, and diabetes in males and females","volume":"23","author":"Navarro","year":"2015","journal-title":"Obesity"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"690484","DOI":"10.3389\/fendo.2021.690484","article-title":"Molecular insulin actions are sexually dimorphic in lipid metabolism","volume":"12","author":"Ortiz-Huidobro","year":"2021","journal-title":"Front Endocrinol"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1365-2605.2012.01255.x","article-title":"No effects of N\u22123 fatty acid supplementation on serum total testosterone levels in older men: the alpha omega trial","volume":"35","author":"Giltay","year":"2012","journal-title":"Int J Androl"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"102204","DOI":"10.1016\/j.plefa.2020.102204","article-title":"Dietary supplementation with docosahexaenoic acid rich fish oil increases circulating levels of testosterone in overweight and obese men","volume":"163","author":"Abbott","year":"2020","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/01635581.2011.570892","article-title":"Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression","volume":"63","author":"Friedrichs","year":"2011","journal-title":"Nutr Cancer"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.3892\/mmr.2015.3813","article-title":"Docosahexaenoic acid inhibits the growth of hormone-dependent prostate cancer cells by promoting the degradation of the androgen receptor","volume":"12","author":"Hu","year":"2015","journal-title":"Mol Med Rep"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/carcin\/22.8.1201","article-title":"Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate Cancer cells","volume":"22","author":"Chung","year":"2001","journal-title":"Carcinogenesis"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1530\/joe-18-0573","article-title":"Emerging role of testosterone in pancreatic \u0392 cell function and insulin secretion","volume":"240","author":"Xu","year":"2019","journal-title":"J Endocrinol"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"415","DOI":"10.31887\/DCNS.2016.18.4\/fmauvais","article-title":"Sex differences in the effects of androgens acting in the central nervous system on metabolism","volume":"18","author":"Morford","year":"2016","journal-title":"Dialogues Clin Neurosci"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0960-0760(02)00217-0","article-title":"5\u03b1-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids","volume":"82","author":"Pham","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"15369","DOI":"10.1021\/bi011384o","article-title":"Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP","volume":"40","author":"Gobinet","year":"2001","journal-title":"Biochemistry"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/pros.22501","article-title":"Mir-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein","volume":"72","author":"Xiao","year":"2012","journal-title":"Prostate"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2131\/jts.42.671","article-title":"Fish oil feeding reverses hepatomegaly and disrupted hepatic function due to the lack of FXR signaling","volume":"42","author":"Miyata","year":"2017","journal-title":"J Toxicol Sci"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1507\/endocrj.K07E-103","article-title":"Molecular basis of endocrine regulation by orphan nuclear receptor small heterodimer partner","volume":"55","author":"Chanda","year":"2008","journal-title":"Endocr J"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.bbadis.2010.10.006","article-title":"Role of nuclear receptor SHP in metabolism and cancer","volume":"1812","author":"Zhang","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"304292","DOI":"10.1155\/2012\/304292","article-title":"A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways","volume":"2012","author":"Garruti","year":"2012","journal-title":"J Lipids"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3390\/metabo11050330","article-title":"Hepatocyte small heterodimer partner mediates sex-specific effects on triglyceride metabolism via androgen receptor in male mice","volume":"11","author":"Palmisano","year":"2021","journal-title":"Meta"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mce.2017.09.001","article-title":"The impact of androgen actions in neurons on metabolic health and disease","volume":"465","author":"Morford","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"295","author":"Ding","year":"2006","journal-title":"JAMA"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.2337\/db13-1505","article-title":"Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome","volume":"63","author":"Yu","year":"2014","journal-title":"Diabetes"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/eje-17-0124","article-title":"Mechanisms in endocrinology: the sexually dimorphic role of androgens in human metabolic disease","volume":"177","author":"Schiffer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1210\/jc.2005-1709","article-title":"Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states","volume":"91","author":"Barrows","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1194\/jlr.M600200-JLR200","article-title":"Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans","volume":"47","author":"Vedala","year":"2006","journal-title":"J Lipid Res"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bbalip.2011.10.011","article-title":"Fish oil: how does it reduce plasma triglycerides?","volume":"1821","author":"Shearer","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s1388-1981(99)00182-1","article-title":"Mobilisation of triacylglycerol stores","volume":"1483","author":"Gibbons","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"ref189","first-page":"23","article-title":"The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly","volume":"95","author":"Gibbons","year":"2002","journal-title":"J R Soc Med"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1042\/bst0320059","article-title":"Synthesis and function of hepatic very-low-density lipoprotein","volume":"32","author":"Gibbons","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.04.005","article-title":"Potential nutritional strategies to prevent and reverse sarcopenia in aging process: role of fish oil-derived \u03a9-3 polyunsaturated fatty acids, wheat oligopeptide and their combined intervention","author":"Pan","year":"2023","journal-title":"J Adv Res"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.2337\/diab.45.3.s24","article-title":"Hyperinsulinemia and triglyceride-rich lipoproteins","volume":"45","author":"Steiner","year":"1996","journal-title":"Diabetes"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/00041433-199706000-00004","article-title":"Fatty acid regulation of very low density lipoprotein production","volume":"8","author":"Lewis","year":"1997","journal-title":"Curr Opin Lipidol"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-2003-41284","article-title":"Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia","volume":"111","author":"Julius","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/hep.30104","article-title":"Fasting inhibits the recruitment of Kinesin-1 to lipid droplets and stalls hepatic triglyceride secretion","volume":"69","author":"Schulze","year":"2019","journal-title":"Hepatology"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ecl.2004.12.001","article-title":"Compensatory hyperinsulinemia and the development of an Atherogenic lipoprotein profile: the Price paid to maintain glucose homeostasis in insulin-resistant individuals","volume":"34","author":"Reaven","year":"2005","journal-title":"Endocrinol Metab Clin N Am"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bbalip.2018.10.008","article-title":"Of mice and men: the physiological role of adipose triglyceride lipase (ATGL)","volume":"1864","author":"Schreiber","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"E653","DOI":"10.1152\/ajpendo.00620.2020","article-title":"100th anniversary of the discovery of insulin perspective: insulin and adipose tissue fatty acid metabolism","volume":"320","author":"Carpentier","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/dmr.5610050306","article-title":"Human ketone body production and utilization studied using tracer techniques: regulation by free fatty acids, insulin, catecholamines, and thyroid hormones","volume":"5","author":"Keller","year":"1989","journal-title":"Diabetes Metab Rev"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2337\/diab.42.6.833","article-title":"Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals","volume":"42","author":"Lewis","year":"1993","journal-title":"Diabetes"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1161\/01.atv.17.7.1454","article-title":"Metabolic basis of hypotriglyceridemic effects of insulin in normal men","volume":"17","author":"Malmstr\u00f6m","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fendo.2020.00252","article-title":"Causes and consequences of hypertriglyceridemia","volume":"11","author":"Packard","year":"2020","journal-title":"Front Endocrinol"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"771","DOI":"10.5551\/jat.RV17023","article-title":"Pathophysiology of diabetic dyslipidemia","volume":"25","author":"Hirano","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s001250050700","article-title":"Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM","volume":"40","author":"Malmstr\u00f6m","year":"1997","journal-title":"Diabetologia"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1073\/pnas.1423952112","article-title":"Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids","volume":"112","author":"Vatner","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2337\/dc20-1644","article-title":"Hepatic insulin resistance is not pathway selective in humans with nonalcoholic fatty liver disease","volume":"44","author":"Ter Horst","year":"2021","journal-title":"Diabetes Care"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"E798","DOI":"10.1152\/ajpendo.1998.275.5.E798","article-title":"Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion","volume":"275","author":"Sidossis","year":"1998","journal-title":"Am J Phys"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/01.atv.19.2.321","article-title":"Glucose phosphorylation is essential for the turnover of neutral lipid and the second stage assembly of triacylglycerol-rich apoB-containing lipoproteins in primary hepatocyte cultures","volume":"19","author":"Brown","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1161\/01.ATV.0000172689.53992.25","article-title":"Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia","volume":"25","author":"Adiels","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20121689","article-title":"Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia","volume":"451","author":"Zammit","year":"2013","journal-title":"Biochem J"},{"key":"ref213","doi-asserted-by":"publisher","first-page":"12958","DOI":"10.1073\/pnas.1713292114","article-title":"Kinesin-dependent mechanism for controlling triglyceride secretion from the liver","volume":"114","author":"Rai","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref214","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1042\/bj3200673","article-title":"Origin of hepatic very-low-density lipoprotein triacylglycerol: the contribution of cellular phospholipid","volume":"320","author":"Wiggins","year":"1996","journal-title":"Biochem J"},{"key":"ref215","doi-asserted-by":"publisher","first-page":"26285","DOI":"10.1074\/jbc.M003520200","article-title":"ADP-ribosylation factor 1 and its activation of phospholipase D are important for the assembly of very low density lipoproteins","volume":"275","author":"Asp","year":"2000","journal-title":"J Biol Chem"},{"key":"ref216","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1016\/S0021-9258(18)81898-1","article-title":"Insulin regulation of lipoprotein lipase activity in 3t3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels","volume":"264","author":"Semenkovich","year":"1989","journal-title":"J Biol Chem"},{"key":"ref217","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1172\/JCI116821","article-title":"Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men","volume":"92","author":"Fried","year":"1993","journal-title":"J Clin Invest"},{"key":"ref218","doi-asserted-by":"publisher","first-page":"E271","DOI":"10.1152\/ajpendo.90920.2008","article-title":"Lipoprotein lipase: from gene to obesity","volume":"297","author":"Wang","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref219","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.atherosclerosis.2014.10.016","article-title":"Lipoprotein lipase: from gene to atherosclerosis","volume":"237","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref220","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0022-2275(20)30473-9","article-title":"Dietary long-chain N-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an Atherogenic lipoprotein phenotype","volume":"43","author":"Khan","year":"2002","journal-title":"J Lipid Res"},{"key":"ref221","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1194\/jlr.M200282-JLR200","article-title":"Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance","volume":"44","author":"Park","year":"2003","journal-title":"J Lipid Res"},{"key":"ref222","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.amjcard.2005.12.024","article-title":"Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids","volume":"98","author":"Davidson","year":"2006","journal-title":"Am J Cardiol"},{"key":"ref223","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01.mol.0000236363.63840.16","article-title":"Why do omega-3 fatty acids lower serum triglycerides?","volume":"17","author":"Harris","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"ref224","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1586\/14779072.6.3.391","article-title":"Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications","volume":"6","author":"Bays","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref225","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2007.11.008","article-title":"Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives","volume":"197","author":"Harris","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref226","doi-asserted-by":"publisher","first-page":"1981S","DOI":"10.1093\/ajcn\/87.6.1981S","article-title":"Role of N-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease","volume":"87","author":"Jacobson","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"ref227","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12944-017-0541-3","article-title":"Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review","volume":"16","author":"Oscarsson","year":"2017","journal-title":"Lipids Health Dis"},{"key":"ref228","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume-title":"Sex and gender factors affecting metabolic homeostasis, diabetes and obesity","author":"Palmisano","year":"2017"},{"key":"ref229","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1074\/jbc.274.1.345","article-title":"The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta","volume":"274","author":"Johansson","year":"1999","journal-title":"J Biol Chem"},{"key":"ref230","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","article-title":"Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins","volume":"325","author":"Walsh","year":"1991","journal-title":"N Engl J Med"},{"key":"ref231","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1172\/JCI115535","article-title":"Mechanism of plasma cholesteryl Ester transfer in hypertriglyceridemia","volume":"88","author":"Mann","year":"1991","journal-title":"J Clin Invest"},{"key":"ref232","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1161\/01.atv.17.12.3542","article-title":"Lipoprotein heterogeneity and apolipoprotein B metabolism","volume":"17","author":"Packard","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref233","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1042\/bst0311066","article-title":"Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein","volume":"31","author":"Packard","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"ref234","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/s0009-9120(03)00078-x","article-title":"Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity","volume":"36","author":"Rashid","year":"2003","journal-title":"Clin Biochem"},{"key":"ref235","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0021-9150(95)05606-8","article-title":"Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL","volume":"118","author":"Murdoch","year":"1995","journal-title":"Atherosclerosis"},{"key":"ref236","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","article-title":"Metabolic origins and clinical significance of LDL heterogeneity","volume":"43","author":"Berneis","year":"2002","journal-title":"J Lipid Res"},{"key":"ref237","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1210\/jcem.86.6.7586","article-title":"The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low\/high density lipoprotein heterogeneity","volume":"86","author":"Carr","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref238","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1194\/jlr.R200017-JLR200","article-title":"Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet","volume":"44","author":"Deeb","year":"2003","journal-title":"J Lipid Res"},{"key":"ref239","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1161\/01.ATV.9.4.485","article-title":"Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women","volume":"9","author":"Despr\u00e9s","year":"1989","journal-title":"Arteriosclerosis"},{"key":"ref240","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1007\/s00125-008-1125-6","article-title":"Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2","volume":"51","author":"van Deursen","year":"2008","journal-title":"Diabetologia"},{"key":"ref241","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: from basic research to clinical practice","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"ref242","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ Res"},{"key":"ref243","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/s1262-3636(07)70213-6","article-title":"New insight into the pathophysiology of lipid abnormalities in type 2 diabetes","volume":"31","author":"Verg\u00e8s","year":"2005","journal-title":"Diabetes Metab"},{"key":"ref244","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/01.ATV.0000154144.73236.f4","article-title":"Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Qu\u00e9bec cardiovascular study","volume":"25","author":"St-Pierre","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref245","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1365-2265.2008.03407.x","article-title":"Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome","volume":"70","author":"Rizzo","year":"2009","journal-title":"Clin Endocrinol"},{"key":"ref246","doi-asserted-by":"publisher","first-page":"e56782","DOI":"10.1371\/journal.pone.0056782","article-title":"Levels of cholesterol in small LDL particles predict atherosclerosis progression and incident CHD in the HDL-atherosclerosis treatment study (HATS)","volume":"8","author":"Williams","year":"2013","journal-title":"PLoS One"},{"key":"ref247","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/atvbaha.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the atherosclerosis risk in communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref248","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2017.07.003","article-title":"Ldl subfractions are associated with incident cardiovascular disease in the Malm\u00f6 prevention project study","volume":"263","author":"Shiffman","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref249","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.plipres.2016.05.001","article-title":"Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults","volume":"63","author":"Stark","year":"2016","journal-title":"Prog Lipid Res"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1020678\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T05:17:47Z","timestamp":1687151867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1020678\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":249,"alternative-id":["10.3389\/fnut.2023.1020678"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1020678","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"article-number":"1020678"}}